Biologics
South Korea’s Celltrion Acquires iQone Healthcare Switzerland to Boost Direct Commercialization of Biosimilars in Europe
Celltrion announces acquisition of iQone Healthcare Switzerland, accelerating direct commercialization of its biosimilars in the European region T...
November 18, 2024 | News
Mabwell's Nectin-4 Targeting ADC Secures IND Approval for Clinical Trials in Perioperative Urothelial Carcinoma and Advanced Solid Tumors
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its novel Nectin-4 targeting ADC (R&D code: 9MW...
November 15, 2024 | News
Chime Biologics and Waterstone Pharmaceuticals Forge Strategic Alliance to Deliver Integrated Solutions for Global ADC Industry
Chime Biologics and Waterstone Pharmaceuticals announce a strategic partnership to provide integrated services for the global Antibody-Drug Conjugate (AD...
November 13, 2024 | News
Lonza Expands Bioconjugation Capabilities in Switzerland with New Manufacturing Suites
The expansion of bioconjugation capabilities will provide additional manufacturing capacity for launch and commercial supply, addressing growing market...
November 12, 2024 | News
GenScript Expands Global Footprint with New Operations and Logistics Hub in Sydney, Australia
GenScript Biotech Corporation ("GenScript"), a global leader in life sciences services and products, has announced the establishment of new operations site...
November 12, 2024 | News
Harbour BioMed Files IND Application in China for Novel Antibody Therapy HBM9378/SKB378 Targeting COPD
Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel ant...
November 11, 2024 | News
Illumina and PHASE Scientific Forge Strategic Partnership to Drive Genomic Innovation in Greater Bay Area
llumina Hong Kong LIMITED (Illumina), a global leader in DNA sequencing and array-based technologies, and PHASE Scientific International Limited (PHASE), a...
November 11, 2024 | News
Aditum Bio and Leads Biolabs Launch Oblenio Bio to Advance First-in-Class Tri-Specific Antibody for Autoimmune Diseases
Aditum Bio and Leads Biolabs announced the formation of Oblenio Bio, which is being formed in conjunction with an exclusive option and license agreeme...
November 08, 2024 | News
MGI Partners with Human Cell Atlas to Accelerate Global Adoption of Single Cell and Spatial Omics Technologies
MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, announced a commercial...
November 08, 2024 | News
AstraZeneca to Create Over 800 Jobs in Singapore with New $1.5 Billion Facility for Precision Cancer Therapies
AstraZeneca plans to hire over 800 employees in Singapore for highly skilled roles ranging from engineering, quality, technical services to global su...
November 08, 2024 | News
BioIVT and KRISHGEN BioSystems Forge Exclusive Agreement to Expand Access to High-Quality Biospecimen Solutions Across South Asia
-BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, announced an exclusive agreement* with KRI...
November 07, 2024 | News
Inocras and Summit Pharmaceuticals Ink MOU to Transform Genomic Medicine in Japan
Inocras Inc. and Summit Pharmaceuticals International Corporation (“SPI”) signed an MOU (Memorandum of understanding) to jointly ex...
November 06, 2024 | News
Duoning Biotech and Branca Bunús Forge Strategic Partnership to Drive Innovation in Transfection Reagents for Biopharma
Duoning Biotechnology Group ("Duoning") announced a strategic partnership agreement with Branca Bunús Ltd. ("Branca Bunús"). Under this agree...
November 06, 2024 | News
Ring Therapeutics Partners with Singapore's A*STAR and SERI to Drive R&D in Ophthalmology, Oncology, and Bioprocessing
Wide-ranging A*STAR and SERI partnership will accelerate the development of novel developmental candidates in the areas of ophthalmology and onco...
November 06, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
